11 March 2002
Credibility of problem-solving therapy and medication for the treatment of depression among primary care patients.
Laurence M Mynors-Wallis, Andrew M ThornettMed Sci Monit 2002; 8(3): CR193-196 :: ID: 420903
Abstract
BACKGROUND: Patient beliefs in the effectiveness of treatment may havean important influence on treatment outcome. MATERIAL/METHODS: Associations between patient beliefs inthe credibility of treatment and outcome were explored in a randomised controlled trial of major depressionin primary care (n=155). The four treatments were antidepressant medication given by research generalpractitioner, problem solving treatment given by research general practitioner or research practice nurseover 12 weeks or a combination of problem solving treatment and antidepressant medication. Patients'belief in the credibility of treatment was assessed using a brief Credibility Scale, that was completedfollowing randomisation and after treatment. Depression outcome was measured at 6, 12 and 52 weeks usingthe Hamilton Rating Scale for depression, and the Beck depression inventory. RESULTS: Pre-treatment,medication treatment was associated with a higher certainty of recovery than was problem-solving treatmentfrom the nurse (p=0.018). Post-treatment, medication and combination treatment were seen as more logicalthan problem-solving treatment from the nurse (p<0.03). Post-treatment medication had higher certainty of recovery and was more highly recommended to a friend. Linear regression demonstrated that the depression outcome measures were not associated with either pre- or post-treatment credibility.
Conclusions: Patients found all four treatments highly credible following their initial explanation. There was a significant difference both pre- and post-treatment in favour of patients finding treatment involving medication more credible than problem-solving from a nurse. Pre- and post-treatment scores of credibility were not associated with outcome
Keywords: Adolescent, Antidepressive Agents, Second-Generation, Depression, fluvoxamine, paroxetine, Psychotherapeutic Processes, Time Factors
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
14 Mar 2024 : Clinical Research
Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate...Med Sci Monit In Press; DOI: 10.12659/MSM.943956
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952